WHO ICTRP trial
Clostridium sarcotica improves intestinal flora to protect cognitive impairment…
ChiCTR2500111814 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500111814 |
|---|---|
| Public title | Clostridium sarcotica improves intestinal flora to protect cognitive impairment in patients with sepsis |
| Scientific title | Clostridium sarcotica improves intestinal flora to protect cognitive impairment in patients with sepsis |
| Primary sponsor | The Second Affiliated Hospital of Anhui Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | sepsis |
| Interventions | Experimental group:Half an hour after three meals, oral/nasogastric Clostridium butyricum viable bacteria powder (1g) was intervened three times a day;Control group:Treatment is carried out according to the guidelines for the diagnosis and… |
| Registration date | Nov 6, 2025 |
| Target size | Experimental group:50;Control group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: